Product Recalls in Utah

Product recalls affecting Utah — including food, drugs, consumer products, medical devices, and vehicles distributed to Utah. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,650 recalls have been distributed to Utah in the last 12 months.

49,677 total recalls
2,650 in last 12 months

Showing 36813700 of 13,417 recalls

DrugOctober 13, 2021· Ultra Seal Corporation

Recalled Item: AERO Tab PAIN RELIEVER (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65...

The Issue: Failed Stability Specifications: Out-of-Specification results observed for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 13, 2021· Ultra Seal Corporation

Recalled Item: ZEE+ painaid ESF Extra-Strength Formula (Acetaminophen 250 mg Recalled by...

The Issue: Failed Stability Specifications: Out-of-Specification results observed for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 12, 2021· Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Recalled Item: Methocarbamol 500mg Tablet Recalled by Bryant Ranch Prepack, Inc. dba BRP...

The Issue: Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 12, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Irbesartan Tablets USP Recalled by Lupin Pharmaceuticals Inc. Due to CGMP...

The Issue: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 12, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Irbesartan Tablets USP Recalled by Lupin Pharmaceuticals Inc. Due to CGMP...

The Issue: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 12, 2021· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: AllerClear D-24 hr Recalled by SUN PHARMACEUTICAL INDUSTRIES INC Due to...

The Issue: Failed Moisture Limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 12, 2021· Teligent Pharma, Inc.

Recalled Item: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL) Recalled by...

The Issue: Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 12, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets USP Recalled by Lupin...

The Issue: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 12, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets USP Recalled by Lupin...

The Issue: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 12, 2021· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine...

The Issue: Failed Moisture Limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 12, 2021· Teligent Pharma, Inc.

Recalled Item: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL) Recalled by...

The Issue: CGMP Deviations: Lots recalled because they were manufactured at the same...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 12, 2021· Teligent Pharma, Inc.

Recalled Item: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL) Recalled by...

The Issue: CGMP Deviations: Lots recalled because they were manufactured at the same...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 12, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Irbesartan Tablets USP Recalled by Lupin Pharmaceuticals Inc. Due to CGMP...

The Issue: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 8, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Imipramine Pamoate Capsules 125 mg Recalled by Lupin Pharmaceuticals Inc....

The Issue: Out of specification result observed in a dissolution test at the 9-month...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Omeprazole Delayed-Release Capsules Recalled by Dr. Reddy's Laboratories,...

The Issue: CGMP Deviations: Customer complaint for the presence of a staple co-mingled...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets Recalled by Dr. Reddy's...

The Issue: Failed Excipient Specifications; product manufactured using an excipient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets Recalled by Dr. Reddy's...

The Issue: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules;...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets Recalled by Dr. Reddy's...

The Issue: Failed Excipient Specifications; product manufactured using an excipient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets Recalled by Dr. Reddy's...

The Issue: Failed Excipient Specifications; product manufactured using an excipient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets Recalled by Dr. Reddy's...

The Issue: Failed Excipient Specifications; product manufactured using an excipient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund